Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-15

Clinical Trial Update: Acetazolamide in Persons With Type 1 Diabetes - Dose Finding [Phase 1, Phase 2]

View source ↗

Summary

A dose-finding study of acetazolamide in individuals with Type 1 diabetes mellitus, combining Phase 1 and Phase 2, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of California, San Diego | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED